Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Switzerland
Switzerland: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 92.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Switzerland, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Switzerland is 92.0%, measured in 2025. That is the highest value across all 18 years on record.
That represents a change of up 1.1% on the previous year and up 15.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Switzerland peaked at 92.0% in 2025 and was at its lowest, 13.0%, in 2008.
Switzerland ranks 56th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.0% | 13.0% | 25.0% | 2 |
| 2010s | 71.6% | 37.0% | 84.0% | 10 |
| 2020s | 89.2% | 86.0% | 92.0% | 6 |
Countries ranked near Switzerland
More health data for Switzerland
- Heat deaths vs projected death rates 1,104 (2090)
- Un projection of annual infant deaths 46 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 50,404 (2025)
- Age population, age 25, female, interpolated 46,962 (2025)
- Age population, age 24, male, interpolated 48,830 (2025)
- Age population, age 24, female, interpolated 45,585 (2025)
- Age population, age 23, male, interpolated 47,356 (2025)
- Age population, age 23, female, interpolated 44,375 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Switzerland?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Switzerland was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Switzerland?
- The highest recorded value was 92.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Switzerland?
- The lowest recorded value was 13.0% in 2008.
- How does Switzerland rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Switzerland ranks 56th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Switzerland?
- Over the last ten years it is up 15.0%. The long-run trend across the full record is rising.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).